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This work describes the isolation and structural determination of pharmacological compounds present in the bark of roots of
Tabernaemontana catharinensis (Apocynaceae). Among the 27 substances detected 12 were identified as terpenoid-indole alkaloids,
2 steroids and 13 pentacyclic triterpenes. Structures were outlined based on HMQC, COSY, DEPT, 13C, and 1H NMR data and MS.
Spectral data  of indole alkaloids were reviewed. An in vitro screening of the extracts and isolated compounds was carried out.
Compounds ibogamine (5), 3-oxo-coronaridine (9) and 12-methoxy-4-methylvoachalotine (MMV) demonstrated effective
cytotoxicity towards SKBR-3 breast adenocarcinoma and C-8161 human melanoma tumor cell lines.
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INTRODUCTION
As part of a phytochemical study of the genus Tabernaemontana
the species T. catharinensis was investigated. The genus
Tabernaemontana pertains to the family Apocynaceae. Recently, 99
species from this genus were reported of which 44 occur in America.
The species identified in Brazil belong to the section Peschiera and
Bonafousia. T. catharinensis is the only species known from Ar-
gentina and Paraguay occurring also in Brazil and Bolivia1.
Tabernaemontana species are well known for their terpenoid-
indole alkaloid contents with approximately 240 structurally
different bases already described. These types of compounds are
responsible for many pharmacological activities such as:
antileishmanial; antibacterial; antitumoral; hypoglycaemic, analgesic
and cardiotonic action2. The section Peschiera contains primarily
indole alkaloids of the type corynathean and heynean3. Besides indole
alkaloids the presence of several pentacyclic triterpenoids was also
evidenced in Tabernaemontana4-6.
In a previous publication we reported on the presence of the
indole alkaloids7. In continuation of our studies on this species the
present communication report the isolation and identification of the
biosynthetically interesting indole alkaloids, steroids and
triterpenoids from root bark extracts.
RESULTS AND DISCUSSION
The root bark was extracted with ethanol and the non-polar
compounds were separated with hexane. EtOAc and n-BuOH extracts
were submitted to acid-base extraction for separation of alkaloids.
In this work, the ethyl acetate basic fraction of the root bark of
T. catharinensis yielded twelve indole alkaloids: coronaridine (1),
coronaridine hydroxyindolenine (2), voacangine (3), voacangine
hydroxyindolenine (4), ibogamine (5), heyneanine (6), voacristine
(7), voacristine hydroxyindolenine (8), 3-oxo-coronaridine (9), 3-
hydroxycoronaridine hydroxyindolenine (10), vobasine (11) and
voachalotine (12). This is the first report on the presence of the
alkaloids 7, 8, 9 and 12 in T. catharinensis while 10 has never been
described. Besides, EH extract yielded ten known triterpenes: 20(30)-
taraxasten-3β-yl (13), iso-lupeyl (14), bauerenyl (15), β-amyrin (16),
pseudotaraxastenyl (17), α-amyrin (18), iso-ursenyl (19), lupeyl (20)
and 20(30)-ursen-3β-yl (21) acetates; and two steroids: stigmasterol
(22) and sitosterol (23). Three known pentacyclic triterpenes were
isolated from neutral fraction EAc2: betulinic acid (25), oleanolic
acid (26) and ursolic acid (27). From the isolated triterpenes
identified, the 13, 15, 17, 19 and 21 are described for the first time
in T. catharinensis and 24 is a new compound.
The reversed-phase ion-pair HPLC system was found to be highly
selective in the separation of various Tabernaemontana alkaloids8.
The alkaloids 2-5, 7 and 8 were separated by reversed-phase ion-
pair HPLC.
All the alkaloids were found to be known tertiary alkaloids
isolated from Tabernaemontana species. Of the 12 alkaloids isolated
10 are of the ibogan class and the other 2 of the corynanthean class.
They were identified by comparison with published data (UV, IR,
1H NMR, 13C NMR and MS)3,5,9-14.
Structures of compounds 1-10, were elucidated on the basis of
the 13C NMR chemical shifts (Table 1) and comparison with the
signals attributed to ibogamine (5).
The relative configurations of C-14, C-16 e C-21 of iboga type
alkaloids remain identical because of the bonds between C(14)-C(3)-
N(4)15. The presence of a methoxy group at C-10, in the indole ring
induce significant dowfield shifts of the resonance signal of alkaloids
3 and 7 (Δδ = + 35 ppm) and Δδ = + 39 ppm of hydroxyindolenine
alkaloids 4 and 8. Moreover this substituent cause upfield of C-o
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(Δδ = -10 and -17 ppm of 3 and 7; Δδ = -8 and –10 ppm of 4 and 8),
downfield of C-p (Δδ = -5 ppm of 3 and 7) and no change of C-m
resonance shifts. Carbomethoxy substituent at C-16 shielded it about
13.0-14.7 ppm in compounds 1, 3 and 6 in comparison with the
same site in structure 5. Interaction of a hydroxyl group at C-19
caused upfield shift of C-15 signal (Δδ = – 10 ppm) and downfield
of C-20 and C-21 resonance signals (Δδ = + 0,5 ppm and Δδ = + 2
ppm), respectively. This effect also suggests a hydrogen bond
between N-4 and that hydroxy substituent. The shifts of the carbons
C-15, C-20 and C-21, very close to those reported by Perera et al.9,
clearly confirm the configuration of 19S for compounds 6, 7 and 8.
In the isolated alkaloids 13C NMR resonance signals near at 88 ppm
and 187 ppm are indicative of the presence of a hydroxy group at C-
7 of structures 2, 4, 8 and 10, shielding C-7 and deshielding C-2,
respectively. Moreover, comparing the nearly identical shift pattern
of structures 10 and 2, the presence of a hydroxy group attached to
the C-3 of compound 10 is denoted by the downfield shift of C-3 by
12 ppm and the interactions of this group causing downfield shifts
of C-14, C-15, C-17 and C-20. Moreover, the hydroxy group at C-3
must present the S configuration due to the cyclic conformation of
isoquinuclidine group allowing a non-ligand interaction between
the OH at C-3 and C-15. The deshielding of C-15 by 5.5 ppm and
shielding of C-21 by 5.0 ppm reinforce this point and confirm this
compound to possess structure 10.
Biogenetic correlation shows that indole alkaloids of corynanthe
type containing a non re-arranged monoterpene unit, as compounds
11 and 12, retain the α configuration for H-15. Furthermore, the link
C(5)-C(16)-C(15) only is allowed if H-3 has the α configuration15.
The carbonyl and the methoxy group of compound 11 resonate at
downfield of 2,7 and 1,8 ppm, respectively due to the proximity of
those groups indicating the S configuration for C-16. 13C NMR spectra
data of those a-acylindole alkaloids also denote the typical anisotropic
effect of indole on the carbonyl of the ester group16.
Alkaloids of the sarpagine type are formed by an indole ring
fused to a quinuclidine system, which confers a relative rigidity to
the structure allowing a more detailed analysis of the stereo effects
of substituents. Upfield resonance of C-17 shows that the CH2OH
group is in the position endo in relation to the indole system, inducing
a hydrogen-hydrogen non-bonded γ–gauche type interaction with
the C-14 that is eclipsed by the C-616.
Fractionation of EAc2 (neutral fraction) resulted in the
purification of pentacyclic triterpenes: betulinic acid (25), oleanolic
acid (26) and ursolic acid (27). On the basis of chemical shifts from
the 13C NMR spectra, isolated triterpenes of the oleanane, ursane
and lupane type were identified17.
The presence of lupane moiety in the triterpenoid 24 was
recognised by chemical shifts and multiplicity of all 13C NMR signals,
deduced by the comparative analysis of the proton noise decoupled
and DEPT spectra. The chemical shifts of H-3 (4.45-4.50 ppm) and
carbon atoms C-3 (80.9 ppm), C-2 (24.1 ppm) and C-4 (38.3 ppm)
of this compound compared with those of triterpenoids 3β-O-
acetyllupeol indicated the presence of an acyl group at the oxygen
atom of C-318. The 1H NMR spectrum displayed a singlet for two
ethylenic protons in a 1,1-disubstituted double bond (4.67 ppm),
this is confirmed by carbon atoms chemical shifts at 110.0 and 150.2
ppm. Chemical shift at 75.6 ppm and the absence of a multiplet at
3.50 ppm indicate the hydroxyl group in the C-19, the DEPT
spectrum confirm that this signal is the quaternary carbon. The
recognition of this presence of this basic skeleton in the natural
esters pointed to the esterification of the hydroxyl function at C-3
with different acyl groups. The acidic methanolysis of the ester
yielded a basic skeleton as the alcoholic portion and a mixture of
the methyl esters as the acidic portion. The mixture of these methyl
esters was recognized by GC/MS analysis. The base peak at m/z 74
in the mass spectra of the methyl esters can be rationalized by
McLafferty rearrangement of the molecular ion to produce olefin
fragment at m/z 196. The molecular ion of the main methyl ester
was detected at m/z 270, together common mass fragments; suggest
that it has an unsaturated long chain with 14 methylenic groups.
The chemical investigation in this work can help the
Table 1. 13C NMR spectra data of indole alkaloids (CDCl3, TMS)
Carbon 1 2 3 4 5 6 7 8 9 10 11 12
2 136.5 189.3 137.3 186.8 141.6 136.9 136.6 186.1 135.6 186.8 134.1 137.2
3   51.5   48.7 51.6   48.6 49.8   51.3 52.3 47.8 172.9   61.1 190.1   47.8
5   53.1   49.0 52.6   49.0 54.1   52.2 51.4 48.0   42.6 43.5 57.2   53.6
6   22.0   33.8 22.2   34.1 20.4   22.9 21.4 33.1   20.9 30.4 20.3   22.3
7 110.2   88.3 109.9   88.3 108.8 109.6 109.4 87.8 109.1   88.2 120.4 105.0
8 128.7 142.6 129.0 144.4 129.5 128.4 128.7 143.7 127.7 141.2 128.5 126.1
9 118.4 126.7 100.7 107.9 117.7 118.3 100.6 108.0 118.2 127.0 120.8 118.3
10 119.1 120.8 154.0 159.1 118.9 119.3 154.0 159.3 119.4 121.0 120.4 118.8
11 121.8 129.1 111.8 113.7 120.8 122.1 112.1 114.0 122.2 129.5 126.7 121.0
12 110.3 121.4 111.1 121.3 110.1 110.5 111.3 121.5 110.5 121.6 111.7 108.7
13 135.4 151.3 130.5 144.8 134.6 135.6 130.7 144.7 133.8 150.9 136.3 138.4
14   27.3   27.0 26.9   27.0 26.2   26.7 26.6 26.4   30.8 29.1 43.0   28.3
15   32.0   32.0 31.6   32.0 31.8   21.4 22.9 22.9   35.3   37.5 30.4   30.3
16   55.0   58.7 55.7   58.5 41.0   54.1 55.9 55.7   55.5   53.4 46.6   53.3
17   36.4   34.8 36.4   34.5 33.9   36.8 36.8 35.2   35.7   35.3 -   63.1
18   11.6   11.5 11.5   11.5 11.8   20.3 20.3 20.3   11.2   11.2 12.3   12.7
19   26.7   26.5 26.4   26.5 27.6   71.3 71.2 71.3   27.5   27.3 120.8 116.0
20   39.1   37.5 38.9   37.5 41.7   39.4 39.4 38.2   38.1   38.0 135.8 136.4
21   57.4   58.3 57.5   58.4 57.6   59.7 59.6 60.1   56.0   53.3 51.8   55.9
22 175.7 173.6 175.4 173.9 - 174.8 174.6 173.0 175.8 171.6 171.2 176.4
CO2CH3   52.5   53.1 52.6   53.1 -   52.9 52.9 53.5   52.9   53.4 50.3   52.1
N1-CH3 - - - - - - - - - - -   29.1
N4-CH3 - - - - - - - - - - 42.3 -
OCH3 - - 56.0  55.7 - - 54.0 57.4 - - - -
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chemotaxonomic identification of Tabernaemontana species such
as: T. affinis Muell. Arg., T. affinis var. lanceolata Muell. Arg., T.
australis Muell. Arg., T. acuminata Muell. Arg., T. Hybrida Hand.-
Maz., T. salicifolia Hand.-Maz., Peschiera albidiflora Miers and
T. hilariana Muell. Arg., which are supposed to be heterotypical
synonymous of T. catharinensis A.DC.1.
Cytotoxic activities of extracts and compounds were evaluated
on SKBR-3 and C-8161 human tumor cell lines (Table 2). Both
extracts and compounds showed considerable cytotoxic activity
against tumor cell lines. We also observed that compound 9 at
moderate or high concentrations shows cytotoxic activity against
SKBR-3 breast adenocarcinoma and C-8161 melanoma tumor cells.
Observations previously showed T. calcarea extracts are a source
of indole alkaloids that exhibit selective cytotoxicity against the
A2780 ovarian cancer cell lines19.
Recent work has demonstrated that betulinic acid is cytotoxic
against other non-melanoma (neuroectodermal and malignant brain
tumor) human tumor varieties20.
In this work we confirm previously observation that T.
catharinensis root bark extract contains compounds with tumor
cytotoxic activity. We also suggest the compounds isolated and
reported by first time here are at least in part responsible for this
property. Importantly our results shows that compounds have
cytotoxic activity in both tumor cell lines tested. The compounds at
the concentration tested in this work against human tumor cell lines
do not shown significant cytotoxic activity on pheripheral blood
mononuclear cells (data not shown). This observations is in
agreement with observations that lupane type triterpenes as betulinic
acid presents selective cytotoxicity against tumor cells and favorable
therapeutic index, even at doses up to 500 mg/kg body weight,
betulinic acid is a very promising new chemotherapeutic agent for
the treatment of cancer20,21. The triterpenes cytotoxic activity
mechanisms on tumor cells remains unclear. Betulinic acid appears
to function by means of inducing apoptosis in cells irrespective of
their p53 status20. Further experiments are necessary to check the
apoptosis induction property of compounds 5 and 9.
EXPERIMENTAL
General
1H and 13C NMR spectra were recorded in CDCl3 at 300 and 75
MHz, respectively. Mass spectra were determined at 70 eV using a
direct inlet system. HPLC was performed on a Shimadzu LC-10AD
instrument with diode array detector.
Plant material and isolation procedure
Roots of T. catharinensis A.DC. were collected in Assis, SP. Voucher
specimen were deposited at the herbarium (SPFR) of the Faculdade de
Filosofia, Ciências e Letras de Ribeirão Preto, USP (Reg. No. 02940).
Dried root bark (950 g) was extracted three times through
maceration with ethanol for ten days. Crude extract (150 g) was
submitted to partition with hexane, ethyl acetate and n-butanol. After
evaporation of the solvent the following extracts were obtained:
hexane, EtOAc and n-BuOH extracts.
The EtOAc and n-BuOH extracts were further submitted to acid-
base partition (Figure 1). Basic fractions EAc 3 and EB 3 were
successively fractionated on silica gel 60 column using hexa-
ne:Me2CO or CHCl3:MeOH. Same fractions of EB 3 were purified
by HPLC using SupelcosilTM LC-18 column (250 x 10 mm, 5 μm)
under isocratic condition (MeOH:n-heptanesulfonic acid, 0.05 M,
pH 5.7; 7:3). The detection was monitored at 280, 313 and 350 nm
and mobile phase flux was 2.0 mL/min. Neutral Fraction (EAc 2)
was fractionated on silica gel 60 column using hexane:acetone (8:2,
7:3 and 1:1). Fractions eluted with hexane:acetone (8:2) were
purified on reverse-phase HPLC using SupelcosilTM LC-18 column
(250 x 10 mm) and MeOH:NaH2PO4 (0.05 M, pH 4.0) (85:15) as
mobile phase. The flow rate was 3.0 mL/min and detection was at
210 nm. Chromatographic system is equipped with diode array
detector. Indole alkaloids 1 to 12 were obtained in this procedure.
Coronaridine (1) (229 mg): 1H NMR (300 MHz, CDCl3): δ 8.32 (s,
NH), 7.45 (dl, J = 6.6 Hz, H-9), 7.21 (dl, J = 6.6 Hz, H-12), 7.11
(ddd, J = 6.1 and 1.1 Hz, H-1), 7.04 (ddd, J = 6.6 and 1.1 Hz, H-10),
3.67 (s, CO2CH3), 0.90(t, J = 7.2 Hz, H-18). 13C NMR (75 MHz,
CDCl3): Table 1. MS (70 eV) m/z (rel.int.): 338 [M+] (100), 254
(3), 214 (18), 148 (9), 136 (59), 130 (14).
Coronaridine hydroxyindolenine (2) (26 mg): 1H NMR (300 MHz,
CDCl3): δ 7.44 (d, J=7Hz, H-10), 7.17-7.38 (m, H-9,11,12), 3.79 (s,
Table 2. Characterization of the in vitro cytotoxic-related anti-tu-
mor effects of the crude extract and compounds
Compounds % Citotoxicity
SKBR-3 cell lines C-8161 cells lines
0.1 mg/mL 1 mg/mL 0.1 mg/mL 1 mg/mL
MMV 12.3 22.7 0.1 15.6
5 NT NT 13.0 70.0
9 43.9 71.5 63.4 79.7
EAc2 20.1 71.4 3.3 17.8
EAc3 8.0 21.1 54.1 58.5
EAc4 9.1 57.3 16.3 42.5
EB2 8.3 30.8 5.4 24.3
EB3 NT NT 13.8 35.8
EB4 1.7 8.14 12.7 32.1
EALA NT NT 14.6 43.6
EALB 32.3 85.6 8.9 24.4
MTT 3.5 10.8 1.6 10.5
Cytotoxicity activity of the extract or isolated compounds was ana-
lyzed by MTT assay as described in materials and methods. MMV
= 12-Methoxy-4-methylvoachalotine7,22. NT = no tested. Values rep-
resent the average of triplicate samples. Data are representative of
at least three independent experiments.
Figure 1. Flux diagram for fractionation of EAc and EB extracts of T.
catharinensis
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H-21), 3.68 (s, CO2CH3), 3.5 (m, H-5’), 2.95 (ddd, J=15.4 and 2
Hz, H-5), 2.70 (m, H-17’, 3), 2.48 (ddd, J=14.4 and 3Hz, H-17),
1.97 (m, H-6’), 1.90 (m, H-14), 1.86 (m, H-6), 1.78 (m, H-15’),
1.42 (m, H-20, 19, 19’), 1.10 (m, H-15), 0.86 (t, J=7.5 Hz, H-18).
13C NMR (75 MHz, CDCl3): Table 1. MS (70 eV) m/z (rel.int.): 354
[M+], 337, 295, 170, 160, 59.
Voacangine (3) (15.5 mg): 1H NMR (300 MHz, CDCl3): δ 7.90 (s,
NH), 7.13 (d, J = 8.6 Hz, H-12), 6.91 (d, J = 2.6 Hz, H-9), 6.80 ppm
(dd, J = 8.6 and 2.6 Hz, H-11), 3.85 (s, OCH3), 3.73 (s, CO2CH3),
0.90 (t, J = 7 Hz, H-18). 13C NMR (75 MHz, CDCl3): Table 1.
Voacangine Hydroxyindolenine (4) (22 mg): 1H NMR (300 MHz,
CDCl3): δ 7.37 (d, J=8.5Hz, H-12), 7.26 (s, NH), 6.90 (d, J=2.5Hz,
H-9), 6.81 (dd, J=8.5 and 2.5 Hz, H-11), 3.81 (s, OCH3), 3.70 (s,
CO2CH3), 0.86 (t, J = 7 Hz, H-18). 13C NMR (75 MHz, CDCl3): Table
1. MS (70 eV) m/z (rel.int.): 384 [M+], 325, 209, 138, 109, 59.
Ibogamine (5) (60 mg): 1H NMR (300 MHz, CDCl3): δ 7.75 (sl,
NH), 7.44 (m, H-9); 7.19 (m, H-12), 7.07 (m, H-10, H-11), 0.89 (t,
J = 7.15 Hz, H-18). 13C NMR (75 MHz, CDCl3): Table 1. MS (70
eV) m/z (rel.int.): 280 [M+] (53), 195 (29), 168 (10), 156 (16), 148
(16), 136 (100).
Heyneanine (6) (94 mg): 1H NMR (300 MHz, CDCl3): δ 8.31 (s,
NH), 7.46 (dl, J=7,5Hz, H-9), 7.25 (dl, J=7.5Hz, H-12), 7.14 (ddd,
J=7.5 e 1.5Hz, H-11), 6.97 (ddd, J=7.5 and 1.5Hz, H-10), 4.17 (dq,
J=6.5 and 2Hz, H-19), 3.88 (s, H-21), 3.72 (s, COOMe), 1.16 (d,
J=6.5Hz, H-18). 13C NMR (75 MHz, CDCl3): Table 1. MS (70 eV)
m/z (rel.int.): 354 [M+] (54), 338 (4), 309 (11), 253 (6), 214 (33),
167 (22), 152 (42), 130 (23), 96 (27), 51(100).
Voacristine (7) (17.4 mg): 1H NMR (300 MHz, CDCl3): δ 8.17 (s,
NH), 7.14 (d, J=8.6 Hz, H-12), 6.90 (d, J=2.6 Hz, H-9), 6.79 (dd,
J=8.6 and 2.6 Hz, H-11), 3.83 (s, OCH3), 3.71 (s, CO2CH3), 1.10 (d,
J=6.4 Hz, H-18). 13C NMR (75 MHz, CDCl3): Table 1. MS (70 eV)
m/z (rel.int.): 368 [M+1 - OH] (100), 325 (1), 244 (15), 160 (20),
148 (11), 136 (61), 122 (20).
Voacristine hydroxyindolenine (8) (8.7 mg): 1H NMR (300 MHz,
CDCl3): δ 7.36 (d, J = 8.3 Hz, H-12), 6.91 (d, J = 3.0 Hz, H-9), 6.82
(dd, J = 8.3 e 2.6 Hz, H-11). 13C NMR (75 MHz, CDCl3): Table 1.
3-Oxo-coronaridine (9) (35 mg): 1H NMR (300 MHz, CDCl3): δ 8.14
(s, NH), 7.47 (d, H-7,5, H-9), 7.22 (d, 7.5, H-12), 7.10 (ddd, J=7.5 and
1.5 Hz, H-10), 7.09 (ddd, J=7.5 and 1.5 Hz, H-11), 3.70 (s, CO2CH3),
0.93 (t, J=7.5 Hz, H-18). 13C NMR (75 MHz, CDCl3): Table 1.
3-Hydroxycoronaridine hydroxyindolenine (10) (5.2 mg): 1H NMR
(300 MHz, CDCl3): shifts not resolved. 13C NMR (75 MHz, CDCl3):
Table 1.
Vobasine (11) (56 mg): 1H NMR (300 MHz, CDCl3): δ 9.02 (s, NH),
7.71 (d, J=9.0 Hz, H-9), 7.33 (d, J=3.4 Hz, H-12), 7.15 (m, H-10
and H-11), 5.45 (q, J=6.0 Hz, H-19), 2.65 (s, NCH3), 2.61 (s,
CO2CH3), 1.71(dd, J=6.8 and 1.8 Hz, H-18). 13C NMR (75 MHz,
CDCl3): Table 1. MS (70 eV) m/z (rel.int.): 352 [M+], 167, 122, 59.
Voachalotine (12) (52.4 mg): 1H NMR (300 MHz, CDCl3): δ 7.8-
6.9 (m, H-9, H-10, H-11, H-12), 5.34 (m, H-19), 3.73 (s, CO2CH3),
3.62 (s, NCH3), 1.63 (d, J=6.6 Hz, H-18). 13C NMR (75 MHz,
CDCl3): Table 1.
Hexane extract was fractionated on a silica gel 60 column and
purified by HPLC using SupelcosilTM LC-18 column (250 x 10 mm,
5 μm) under isocratic condition (MeOH as mobile phase), the
absorbance was 210 nm and mobile phase flux was 3.0 mL/min.
Fractionation of hexane extracts from the root bark of T.
catharinensis resulted in the separation of fractions containing
triterpenes (EH 1.4 and EH 1.7) and steroids (EH 1.10). Further
purification of EH 1.4 by reversed phase HPLC, produced pooled
fractions: EH 1.4.1 (Rt= 18.5-21 min), EH 1.4.2 (Rt= 21.5-23 min),
EH 1.4.3 (Rt= 26-32 min) and EH 1.4.4 (Rt= 32-34 min).
Fractions EH 1.4.1 (15, 22) (27 mg); EH 1.4.2 (21) (23 mg); EH
1.4.3 (14, 17, 18, 19, 20) (54.7 mg); EH 1.4.4 (16, 18, 19) (49.8
mg); EH 1.10 (22, 23) (106.2 mg). 13C NMR (75 MHz, CDCl3):
154.5 (C-20), 107.1 (C-30) (14); 149.9 (C-20), 109.4 (C-29) (15);
116.2 (C-7), 145.4 (C-8) (16); 121.6 (C-12), 145.1 (C-13) (17);
118.8 (C-19), 139.8 (C-20) (18); 124.3 (C-12), 139.6 (C-13) (19);
159.1 (C-14), 116.4 (C-15) (20); 150.9 (C-20), 109.3 (C-29) (21);
153.2 (C-20), 107.0 (C-30) (22); 140.7 (C-5), 121.6 (C-6) (22);
140.7 (C-5), 121.6 (C-6), 138.2 (C-22), 129.2 (C-23) (23).
Fraction EH 1.7 was fractionated on a silica gel 60 column using
hexane:EtOAc afforded 45.9 mg of the triterpenoid 24. 1H NMR (300
MHz, CDCl3): δ 4.67 (s, H-29), 4.47 (m, H-3), 2.28 (t, J=7.5 Hz, H-
2’a,b), 2.10-1.20 (m), 1.64 (s, H-30), 1.15-0.82 (s, CH3). 13C NMR
(75 MHz, CDCl3): 39.0 (C-1), 24.1(C-2), 80.9(C-3), 38.3(C-4),
56.3(C-5), 18.5(C-6), 35.5(C-7), 40.7(C-8), 50.9(C-9), 37.4(C-10),
21.9(C-11), 25.0(C-12), 38.3(C-13), 42.6(C-14), 27.9(C-15), 35.2(C-
16), 50.4(C-17), 49.8(C-18), 75.6(C-19), 150.2(C-20), 32.3(C-21),
39.5(C-22), 28.3(C-23), 15.8(C-24), 16.6(C-25), 16.9(C-26), 14.5(C-
27), 19.1(C-28), 110.0(C-29), 20.3(C-30), 174.0(C-1´), 35.2(C-2´),
25.5(C-3´), 29(C-4´ to C-13´), 31.6(C-14´), 21.9(C-15´), 14.5(C-16´).
Figure 2. Structure of indole alkaloids (1-12 and MMV) and triterpene methyl
ester (24) isolated of the root bark of T. catharinensis
24 Quim. NovaPereira et al.
Acidic methanolysis of 24. The acidic methanolysis was performed
according Sobrinho et al.18. Compound 24 (45.9 mg) was refluxed for 6
h with methanol (5 mL) and HCl (1 mL). After cooling, the solution
was extracted with CHCl3. The CHCl3 extract was washed with H2O,
dried with anhydrous Na2SO4 and concentrated under vacuum,
furnishing a 3-hydroxyl compound and a mixture of methyl esters, after
chromatography on a silica gel column. Analysis of methyl esters mixture
was performed by GC/MS. EIMS of main methyl ester (70 eV), m/z
(rel.int.): 270 (M+, 1), 239 (1), 227 (2), 199 (1), 143 (6), 129 (3), 101
(4), 97 (4), 88 (4), 87 (53), 83 (6), 75 (18), 74 (100).
Tumor cell lines culture
The SKBR-3 human breast adenocarcinoma and C-8161 human
melanoma tumor cell lines was obtained from the American Type
Culture Collection (ATCC, Rockville, MD, USA). The tumor cell
lines were cultured and maintained in RPMI 1640 medium
supplemented with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate,
4.5 g/L glucose, 10 mM HEPES, 1.0 mM sodium pyruvate, 10%
fetal bovine serum, 100 units/ml penicillin and 100 μg/mL
streptomycin. All cell lines were maintained at 37 °C in an
atmosphere of 5% CO2 and 95% air with more than 95% humidity.
Tumor cytotoxic activity
Tumor cells cytotoxic activity of substances was assessed by (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
as previosly described19. Briefly, tumor cells cultured in appropriate
flasks and maintained in continuously exponential growth were
detached with 0.05% trypsin, 0.02% EDTA in calcium-free
phosphate buffered saline (PBS) and washed 3 times with RPMI
medium at 1000 rpm/15 min/10 °C. Cells were placed in 96-well
plates at a density of 1×105 cells per well. After 24 h of culture, the
medium was removed and fresh medium, with or without different
concentrations of indicated extracts/compounds or control drug
Methotrexate (10–0.01 mg/mL), was added to the wells and
incubated for 24 h. At the end of treatment period, 10 μL of MTT
(10 mg/mL) was added to wells, and cells were incubated for a
further 4 h. Finally, 50 μL of 20% sodium dodecyl sulfate solution
was supplied to each well. Formazan crystals were dissolved at 37
ºC overnight. The absorbance of each well was read on a microplate
reader at a wavelength of 540 nm. Cytotoxic rate was calculated as
follows: % of cytotoxicity of compounds = 1 - Absorbance drug
treated/Absorbance control x l00.
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